12. EHF-THERAPY OF PATIENTS WITH VERTEBRAGENE
NEURODYSTROPHIC PSEUDOCARDIALGIA (SYNDROME OF MIDDLE
SCALENE MUSCLE)
TESTS WERE CARRIED OUT IN TOMSK RESEARCH INSTITUTE OF BALNEOLOGY AND
PHYSIOTHERAPY OF THE RUSSIAN FEDERATION HEALTH MINISTRY.
Description of the method. The method for treatment of patients with syndrome of middle
scalene muscle by EHF-therapy is proposed.
Indications
Syndrome of middle scalene muscle with moderate, expressed and full-blown pain
manifestations, both with debut of disease and chronic recurrent clinical course.
Results
68 patients with syndrome of middle scalene muscle were treated. Positive changes of clinical
symptom group indices were observed: pain reduction of 58 % in the scapula; reduction of
morbidity 71-74 % in zones of neuroosteofibrosis (middle scalene muscle, front-upper
scapular painful point, middle and lower portion of anterior serratus muscle); reduction of
neurovascular disorders of 31 %; increase of head flexion and head rotation to healthy side by
17 % and 12 % accordingly; development of sedative effect on 4-th day of treatment.
Positive dynamics of clinical syndrome indices was revealed: the amplitude of M-answer of
anterior serratus muscle of the target affected part rose by 2,4 times it was proved about
increasing of the amount of systole onflow of the affected area and showed improvement of
functioning of the investigated neuromuscular system. Positive dynamics was observed on the
part of conductivity parameters of biologically active points of the target affected part (Nv2,
Nvlb, Aglc, Ðrl, Ðr2): at that values of mezor and average deflection of daily conductivity
from 50 c.u. of patients are normalized.
On the basis of effectiveness criteria evaluation patient state with syndromes of vertebral
column osteochondrosis "significant improvement" was observed at 28 %, "improvement" - at
50 %, "minor improvement" - at 18 %. Thus, efficiency of treatment by this technique was 96
%.